Company intelligence / Profile preview

Pivotal bioVenture Partners

San Francisco, California, United Statespivotallifesciences.com ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Pivotal bioVenture Partners does not develop drugs itself but has invested in over forty-four biotech and pharma startups across North America and Europe. Their portfolio includes companies at all stages of development—from discovery through early clinical trials to commercialization—with several high-profile exits and public offerings among their investments.

Modalities: Small moleculeMonoclonal antibodyBiologicGene therapyCell therapyRNA therapy
Industry: Investors

Partnerships

Chinook Therapeutics/SanReno Therapeutics joint ventureFrazier Healthcare Partners

Beyond the preview

Go deeper on Pivotal bioVenture Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pivotal bioVenture Partners.

Explore the full profile